SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19

被引:17
|
作者
Arduini, Ariana [1 ,2 ]
Laprise, Frederique [1 ,3 ]
Liang, Chen [1 ,2 ,3 ]
机构
[1] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Med, Montreal, PQ H3G 2M1, Canada
[3] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada
来源
VIRUSES-BASEL | 2023年 / 15卷 / 04期
基金
加拿大健康研究院;
关键词
SARS-CoV-2; COVID-19; ORF8; accessory protein; immune evasion; viral mimicry; SARS-CORONAVIRUS; ACCESSORY PROTEINS; SIGNALING PATHWAY; VARIANT; DELETION; VIRUS;
D O I
10.3390/v15040871
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The COVID-19 pandemic has resulted in upwards of 6.8 million deaths over the past three years, and the frequent emergence of variants continues to strain global health. Although vaccines have greatly helped mitigate disease severity, SARS-CoV-2 is likely to remain endemic, making it critical to understand its viral mechanisms contributing to pathogenesis and discover new antiviral therapeutics. To efficiently infect, this virus uses a diverse set of strategies to evade host immunity, accounting for its high pathogenicity and rapid spread throughout the COVID-19 pandemic. Behind some of these critical host evasion strategies is the accessory protein Open Reading Frame 8 (ORF8), which has gained recognition in SARS-CoV-2 pathogenesis due to its hypervariability, secretory property, and unique structure. This review discusses the current knowledge on SARS-CoV-2 ORF8 and proposes actualized functional models describing its pivotal roles in both viral replication and immune evasion. A better understanding of ORF8's interactions with host and viral factors is expected to reveal essential pathogenic strategies utilized by SARS-CoV-2 and inspire the development of novel therapeutics to improve COVID-19 disease outcomes.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta
    Rashid, Farooq
    Dzakah, Emmanuel Enoch
    Wang, Haiying
    Tang, Shixing
    VIRUS RESEARCH, 2021, 296
  • [32] The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
    Li, Jin-Yan
    Liao, Ce-Heng
    Wang, Qiong
    Tan, Yong-Jun
    Luo, Rui
    Qiu, Ye
    Ge, Xing-Yi
    VIRUS RESEARCH, 2020, 286
  • [33] Defective ORF8 dimerization in SARS-CoV-2 delta variant leads to a better adaptive immune response due to abrogation of ORF8-MHC1 interaction
    Chaudhari, Armi M.
    Singh, Indra
    Joshi, Madhvi
    Patel, Amrutlal
    Joshi, Chaitanya
    MOLECULAR DIVERSITY, 2023, 27 (01) : 45 - 57
  • [34] The relevance of selenium to viral disease with special reference to SARS-CoV-2 and COVID-19
    Rayman, Margaret P.
    Taylor, Ethan Will
    Zhang, Jinsong
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2023, 82 (01) : 1 - 12
  • [35] The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)
    Domingo, Pere
    Mur, Isabel
    Pomar, Virginia
    Corominas, Hector
    Casademont, Jordi
    Benito, Natividad de
    EBIOMEDICINE, 2020, 58
  • [36] SARS-CoV-2 and COVID-19: A Narrative Review
    Blann, A. D.
    Heitmar, R.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2022, 79
  • [37] SARS-CoV-2: Remarks on the COVID-19 Pandemic
    Egbert Piasecki
    Archivum Immunologiae et Therapiae Experimentalis, 2020, 68
  • [38] SARS-CoV-2: Remarks on the COVID-19 Pandemic
    Piasecki, Egbert
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2020, 68 (06)
  • [39] SARS-CoV-2/COVID-19: a primer for cardiologists
    de Vries, A. A. F.
    NETHERLANDS HEART JOURNAL, 2020, 28 (7-8) : 366 - 383
  • [40] Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19
    Anirudhan, Varada
    Lee, Hyun
    Cheng, Han
    Cooper, Laura
    Rong, Lijun
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (05) : 2722 - 2734